section name header

Information ⬇

Editors

PanuK.Luukkonen
PerttuSahlman
HelkaParviainen

Alcoholic Liver Disease (Ald)

Essentials

  • ALD is a continuum from fatty liver to steatohepatitis and liver cirrhosis.
  • ALD increases the risk of hepatocellular carcinoma, and some patients develop acute alcoholic hepatitis resulting from a drinking spree.
  • The risk limit for alcohol consumption is 20 g a day of absolute alcohol for women and 30 g for men - however, there are no completely safe limits for alcohol consumption.
  • Binge drinking is harmful regardless of the average alcohol consumption.
  • The aim is to recognize early stages of alcoholic liver disease, to stop alcohol consumption in time before the disease progresses and to treat complications of advanced disease.
  • A person may have several risk factors for liver disease (such as alcohol and obesity), which should be treated simultaneously. Alcohol also speeds up the progression of liver damage from other causes (NAFLD, chronic viral hepatitis).
  • See also the article Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Metabolic Dysfunction-Associated Steatotic Liver Disease (Masld) and Steatohepatitis (Mash).

Examination and diagnosis

  • For diagnosis, a history of high alcohol consumption and proof of liver damage is required.
    • Alcohol history
    • Proof of high alcohol consumption
      • AUDIT test to assess alcohol consumption
      • If the alcohol history remains uncertain or unreliable, other indicators can be used, as necessary.
        • Direct alcohol markers (breath alcohol, serum ethanol, blood phosphatidylethanol)
        • Indirect alcohol markers (AST/ALT ratio, MCV, CDT) are low in sensitivity and should therefore be combined with other laboratory tests, history and clinical findings
        • See also Recognition of alcohol and drug abuse Recognition of Alcohol and Drug Abuse
  • Workup
  • Detecting concomitant risk factors for liver disease
    • Family history of cirrhosis, obesity Raising the Subject of Obesity, and Assessment of Obesity, metabolic syndrome Metabolic Syndrome, diabetes Comprehensive Treatment and Follow-Up of Type 2 Diabetes, different types of viral hepatitis Viral Hepatitis, hepatotoxic medication (see locally available drug database), natural products and smoking
  • Detecting alcoholic hepatitis
    • Acute jaundice, liver failure, general symptoms, resulting from excessive drinking
    • Patients with alcoholic hepatitis need emergency specialized care.
  • Detecting liver cirrhosis
    • See also Cirrhosis of the liver Cirrhosis of the Liver.
    • Clinical signs of liver cirrhosis
      • Spider naevi, palmar erythema, jaundice, ascites, muscular wasting
    • Some patients with cirrhosis may be asymptomatic and may have normal liver enzyme values. Detecting such ‘silent' cirrhosis is essential for the prognosis and for screening for complications particularly in heavy drinkers.
    • Screening for complications
  • Detection of other diseases associated with ALD
    • GI cancers Colorectal Cancer, cancers in the head and neck regions Cancers of the Head and Neck, respiratory tract cancers Lung Cancers, alcohol-related neurological diseases Neurological Disorders and Alcohol, dilated cardiomyopathy Dilated Cardiomyopathy, hypertension Hypertension: Investigations, Treatment Initiation and Non-Pharmacological Treatment, arrhythmias Symptoms of Arrhythmia and Examination of an Arrhythmia Patient

Treatment

  • The most important treatment improving the prognosis is stopping alcohol consumption.
    • This will improve the prognosis at any stage of the disease.
    • It will reverse histological changes in the liver.
    • A mini intervention Brief Interventions for Risky Use of Alcohol should be performed for all heavy users.
    • Appropriate patients should be referred for substance abuse treatment Providing Care for an Alcohol or Drug Abuser
    • See also Pharmacotherapy in alcohol dependence Drugs Used in Alcohol Dependence.
  • Management of concomitant risk factors of liver disease
    • Weight reduction, avoiding medication and natural products that put a strain on the liver, smoking cessation
  • Treatment plans for patients with mild disease should be made in primary health care.
    • If drinking continues, about 20% of patients with ALD will develop cirrhosis.
    • The aim of follow-up is to motivate patients to reduce their alcohol consumption and to detect any signs of progressive disease or complications requiring treatment.

Consulting specialized care

  • Specialized care should be consulted if the patient has any signs suggesting liver cirrhosis.
    • Clinical or biochemical signs, imaging or elastography
  • In specialized care
    • Confirming the diagnosis in unclear cases
    • Planning the treatment of liver cirrhosis and guidance for further follow-up in primary health care
      • Exclusion of hepatocellular carcinoma (ultrasonography)
      • Screening for, and treatment of, oesophageal varices (gastroscopy)
      • Treatment of other complications of portal hypertension (ascites, encephalopathy, hepatorenal syndrome)
      • Assessment of the possibility of liver transplantation in selected patients who were capable of stopping their alcohol consumption and whose liver cirrhosis remains decompensated (ascites, jaundice, encephalopathy, recurrent bleeding from oesophageal varices) despite abstinence
  • Consultation of an addiction medicine specialist and a social worker
  • The prognosis of patients with liver cirrhosis who continue to drink after appropriate primary assessment is very poor, and in most cases they do not benefit from follow-up in specialized care.

Workup in patients with alcoholic liver disease

Basic investigationsDifferential diagnostic tests as considered appropriateAssessment of severityFinding complications in progressed disease
Basic blood count, ALT, AST, ALP, Bil, PT or INR, Alb, Prealb, potassium, sodium, creatinine and fasting glucoseHBsAg, anti-HCV antibodies, anti-smooth muscle antibodies, antimitochondrial antibodies, antinuclear antibodies, anti-transglutaminase antibodies, IgG, IgA, IgM, Fe, transferrin saturation level, ferritin, alpha1 antitrypsin(APRI, FIB-4 fibrosis markers as considered appropriate)Oesophageal varices
Upper abdominal ultrasonographyElastography, if availableHepatocellular cancer
In patients with cirrhosis, severity of disease based on the Child-Pugh score 1http://www.mdcalc.com/child-pugh-score-cirrhosis-mortalityAscites
Encephalopathy

Related Keywords ⬆

ATC Code:

Primary/Secondary Keywords